Ventyx Biosciences

Forecast & Rating8 analysts currently cover Ventyx Biosciences, with about 12.5% giving a positive rating — meaning they expect the stock to rise. The average price target is $14.14, about 1.0% upside from the current price of $14.00. Price targets range from $9.00 to $20.00 — a wide spread, showing clear disagreement over just how much Ventyx Biosciences can rise. Historically, about 51.6% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Ventyx Biosciences's outlook. Data as of Jan 12, 2026; for reference only and not investment advice.